Effect of the somatostatin analogue SMS 201-995 on faecal fat excretion in acromegaly.
McGregor
A R
AR
Department of Endocrinology and Gastroenterology, Princess Margaret Hospital, Christchurch, New Zealand.
Troughton
W D
WD
Donald
R A
RA
Espiner
E A
EA
D000172:Acromegaly / Q000150:complications / Q000378:metabolism*; D000368:Aged; D002769:Cholelithiasis / Q000150:complications; D005243:Feces / Q000032:analysis*; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D009747:Nutritional Physiological Phenomena; D015282:Octreotide / Q000494:pharmacology*; D013004:Somatostatin / Q000031:analogs & derivatives*
D013004:Somatostatin; D013006:Growth Hormone; D015282:Octreotide